Zim Laboratories
BSE: 541400 | NSE: ZIMLAB | ISIN: INE518E01015 | SECTOR: Biotechnology & DrugsOpen
96.30High
97.50Low
94.50Prev Close
95.40P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
4.61BVolume
22.86KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
-
Company Description
- Biotechnology & Drugs
BSE
541400NSE
ZIMLABISIN
INE518E01015
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Company Officers
Anwar Daud
Executive Chairman of the Board, Managing DirectorShyam Patro
Chief Financial OfficerZulfiquar Kamal
Director - Finance, Executive DirectorPiyush Nikhade
Compliance Officer, Company SecretaryNiraj Dhadiwal
Director - Business DevelopmentPrakash Sapkal
Director - Operations